Home
Conditions
Leukemia, Lymphoid

Clinical trial condition

Leukemia, Lymphoid

Explore clinical trials studying Leukemia, Lymphoid. Study availability and eligibility vary by location and protocol.

3,016 public trials 548 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Lymphoid trial results

Recruiting

Zanubrutinib in Patients With Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma and Follicular Lymphoma

NCT05326308

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +30 more
Locations: Universitätsklinikum Salzburg, Klinik für Innere Medizin III Salzburg, Austria

Lübecker Onkologische Schwerpunktpraxis Lübeck, Schleswig-Holstein, Germany

View Trial Details

Recruiting

PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability

NCT04321200

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Childrens Hospital of Philadelphia Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

Safety Study of CC312 in Adult Patients With Relapsed/Refractory CD19 Positive B-cell Hematologic Malignancies

NCT06037018

Conditions: Acute Lymphoblastic Leukaemia, Chronic Disease, Chronic Lymphocytic Leukemia, +19 more
Locations: InstituteHBDH Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Phase I Clinical Trial of CART Cell Therapy for Refractory/Relapsed Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults

NCT06709469

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Hospital Universitario La Paz Madrid, Spain

View Trial Details

Recruiting

Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors

NCT05643235

Conditions: Arrhythmias, Cardiac, Atrial Fibrillation, Blood Protein Disorders, +35 more
Locations: Northwell (Northshore University/Long Island Jewish Hospitals) New Hyde Park, New York, United States

View Trial Details

Recruiting

Multicenter Study on Rehabilitation Medical Data for Pediatric Big Brain Development

NCT06367920

Conditions: Healthy, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: CHA Bundang Medical Center, CHA University Seongnam-si, Gyeonggi-do, South Korea

View Trial Details

Recruiting

HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

NCT05745714

Conditions: Acute Lymphoblastic Leukemia, in Relapse, Disease Attributes, Hematologic Diseases, +19 more
Locations: St. Anna Kinderspital Vienna, Austria

Universitair Ziekenhuis Gent Ghent, Belgium

Rigshospitalet Copenhagen Copenhagen, Denmark

Helsinki University Hospital, New Children's Hospital Helsinki, Finland

View all 33 locations

View Trial Details

Recruiting

HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies

NCT05658640

Conditions: Acute Lymphoblastic Leukemia, in Relapse, Disease Attributes, Hematologic Diseases, +19 more
Locations: St. Anna Kinderspital Vienna, Austria

Universitair Ziekenhuis Gent Ghent, Belgium

Rigshospitalet Copenhagen Copenhagen, Denmark

Helsinki University Hospital, New Children's Hospital Helsinki, Finland

View all 36 locations

View Trial Details

Recruiting

HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

NCT05751044

Conditions: Acute Lymphoblastic Leukemia, Disease Attributes, Hematologic Diseases, +19 more
Locations: St. Anna Kinderspital Vienna, Austria

Universitair Ziekenhuis Gent Ghent, Belgium

Rigshospitalet Copenhagen Copenhagen, Denmark

Helsinki University Hospital, New Children's Hospital Helsinki, Finland

View all 33 locations

View Trial Details

Recruiting

Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment

NCT06784167

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +33 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Leukemia, Lymphoid

Leukemia, Lymphoid trial results

Related conditions